Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
6.04
Dollar change
+0.38
Percentage change
6.71
%
IndexRUT P/E- EPS (ttm)-0.55 Insider Own21.80% Shs Outstand119.16M Perf Week-2.27%
Market Cap738.57M Forward P/E- EPS next Y-1.07 Insider Trans19.23% Shs Float95.63M Perf Month18.43%
Income-57.77M PEG- EPS next Q-0.19 Inst Own74.64% Short Float3.13% Perf Quarter20.56%
Sales113.31M P/S6.52 EPS this Y-87.04% Inst Trans-0.41% Short Ratio3.22 Perf Half Y14.18%
Book/sh0.33 P/B18.16 EPS next Y-5.74% ROA-27.42% Short Interest3.00M Perf Year61.50%
Cash/sh1.64 P/C3.69 EPS next 5Y- ROE-1123.17% 52W Range3.15 - 7.67 Perf YTD19.60%
Dividend Est.- P/FCF- EPS past 5Y36.03% ROI-79.24% 52W High-21.25% Beta-1.15
Dividend TTM- Quick Ratio1.26 Sales past 5Y610.91% Gross Margin91.88% 52W Low91.74% ATR (14)0.45
Dividend Ex-Date- Current Ratio1.26 EPS Y/Y TTM74.09% Oper. Margin-60.01% RSI (14)55.96 Volatility5.85% 9.11%
Employees268 Debt/Eq0.68 Sales Y/Y TTM3005.10% Profit Margin-50.99% Recom1.50 Target Price13.00
Option/ShortYes / Yes LT Debt/Eq0.53 EPS Q/Q68.11% Payout- Rel Volume0.44 Prev Close5.66
Sales Surprise46.27% EPS Surprise33.83% Sales Q/Q2245.12% EarningsMar 06 BMO Avg Volume930.36K Price6.04
SMA201.52% SMA5022.41% SMA20023.73% Trades Volume413,072 Change6.71%
Date Action Analyst Rating Change Price Target Change
Dec-19-23Upgrade Leerink Partners Market Perform → Outperform $5 → $12
Jul-05-23Initiated Raymond James Outperform $7
May-24-23Downgrade Jefferies Buy → Hold $7 → $5
Dec-15-20Resumed H.C. Wainwright Buy $20
Oct-23-20Initiated RBC Capital Mkts Sector Perform $13
Dec-31-19Downgrade SVB Leerink Outperform → Mkt Perform $33 → $10
Nov-01-19Initiated Guggenheim Buy $43
Jul-15-19Initiated Cowen Market Perform
Apr-17-19Reiterated H.C. Wainwright Buy $49 → $33
Aug-07-18Initiated Stifel Buy $56
Mar-27-24 08:30AM
Mar-15-24 08:18AM
Mar-07-24 10:47AM
Mar-06-24 12:51PM
07:51AM
07:30AM Loading…
07:30AM
Feb-28-24 08:30AM
04:16AM
Feb-27-24 08:30AM
Feb-06-24 01:17PM
Jan-31-24 01:21PM
Jan-08-24 08:00AM
Jan-03-24 08:30AM
Dec-15-23 08:30AM
Dec-07-23 07:00AM
04:10PM Loading…
Dec-06-23 04:10PM
04:08PM
Nov-22-23 08:30AM
Nov-11-23 12:09PM
Nov-09-23 08:38AM
07:43AM
07:30AM
Nov-03-23 04:05PM
Sep-29-23 05:47AM
Sep-28-23 04:15PM
Sep-25-23 08:30AM
Sep-06-23 08:30AM
Sep-05-23 07:30AM
Aug-23-23 11:13AM
Aug-17-23 08:44AM
06:40AM Loading…
06:40AM
Aug-10-23 12:40PM
Aug-08-23 06:02AM
Aug-04-23 06:45AM
Aug-03-23 08:55AM
07:53AM
07:30AM
Jul-27-23 08:30AM
Jul-06-23 08:40AM
Jun-26-23 08:30AM
Jun-19-23 08:00AM
May-23-23 07:30AM
May-16-23 08:30AM
May-08-23 06:03AM
May-05-23 06:19AM
May-03-23 08:55AM
07:49AM
07:30AM
Apr-26-23 08:30AM
Apr-20-23 08:30AM
Mar-29-23 08:54AM
08:00AM
Mar-24-23 07:36AM
Mar-22-23 08:45AM
07:30AM
Mar-02-23 08:30AM
Feb-14-23 12:00PM
09:35AM
Feb-09-23 04:05PM
Jan-25-23 06:06AM
Jan-13-23 07:26AM
Jan-03-23 05:40AM
Dec-30-22 12:00PM
09:03AM
Dec-19-22 01:04PM
07:37AM
Dec-15-22 09:07AM
06:11AM
Dec-13-22 11:27AM
09:51AM
07:30AM
Nov-10-22 08:45AM
07:30AM
Nov-09-22 08:30AM
Nov-03-22 08:30AM
Oct-17-22 11:27AM
Oct-12-22 02:35PM
01:35PM
Oct-03-22 08:30AM
Sep-28-22 01:30PM
Sep-27-22 08:30AM
Sep-21-22 11:39AM
Sep-20-22 12:44PM
07:30AM
Sep-16-22 08:30AM
Aug-13-22 08:12AM
Aug-11-22 03:18PM
08:45AM
07:30AM
Aug-03-22 06:15PM
Jul-28-22 08:30AM
Jul-20-22 10:05AM
Jun-20-22 09:54AM
Jun-14-22 09:00AM
May-25-22 08:30AM
May-13-22 02:51PM
May-12-22 08:45AM
07:30AM
May-10-22 08:30AM
May-05-22 01:21PM
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RA CAPITAL MANAGEMENT, L.P.DirectorDec 11 '23Buy5.001,000,0005,000,00019,202,009Dec 13 04:33 PM
GSK plc10% OwnerDec 07 '23Buy5.003,300,00016,500,00013,983,761Jan 30 04:39 PM
Moran KyleChief Financial OfficerAug 23 '23Sale4.7537,062176,11946,120Aug 23 09:15 PM